Phenylethanolamine derivatives as Beta-2 agonists

Details for Australian Patent Application No. 2005223488 (hide)

Owner Pfizer Inc.

Inventors James, Kim; Lunn, Graham; Lewthwaite, Russell Andrew; Price, David Anthony; Glossop, Paul Alan; Lane, Charlotte Alice Louise; Bunnage, Mark Edward; Brown, Alan Daniel

Agent Spruson & Ferguson

Pub. Number AU-A-2005223488

PCT Pub. Number WO2005/090287

Priority 60/591,790 27.07.04 US; 0425064.3 12.11.04 GB; 04290725.3 17.03.04 EP

Filing date 10 March 2005

Wipo publication date 29 September 2005

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

C07C 237/20 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07D 217/06 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/090287 Priority application(s): WO2005/090287

9 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223491-Crystalline form of atorvastatin hemi calcium

2005223486-Polymorphic and amorphous forms of 2,5-Dimethyl-2H-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((e)-2-pyridin-2-yl-vinyl)-1 H-indasol-6-ylamino]-phenyl}-amide